SCHEMBL15910991

SCHEMBL15910991

C=C(C)C(=O)OCCOc1c(OC)cccc1OC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.54
▸ ALDH1A1 P00352 3/20 0.51
▸ L3MBTL1 Q9Y468 2/20 0.51
▸ LMNA P02545 2/20 0.51
▸ MAPT P10636 1/20 0.51
▸ MAPK1 P28482 1/20 0.49
▸ GAA P10253 1/20 0.48
▸ TSHR P16473 1/20 0.47
▸ THRB P10828 1/20 0.44
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ POLB P06746 2/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ APEX1 P27695 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15910690 0.93 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1L3MBTL1LMNAMAPT
SCHEMBL15910699 0.93 SMN1; SMN2 (0.62) SMN1; SMN2ALDH1A1L3MBTL1LMNAMAPT
SCHEMBL15910892 0.91 SMN1; SMN2 (0.56) SMN1; SMN2ALDH1A1L3MBTL1LMNAMAPT
SCHEMBL15910765 0.91 SMN1; SMN2 (0.56) SMN1; SMN2ALDH1A1L3MBTL1LMNAMAPT
SCHEMBL8363546 0.86 NPSR1 (0.57) SMN1; SMN2ALDH1A1L3MBTL1LMNAMAPT
SCHEMBL10580556 0.82 THRB (0.50) SMN1; SMN2ALDH1A1L3MBTL1LMNAMAPT
SCHEMBL27882618 0.82 CA12 (0.44) SMN1; SMN2ALDH1A1TSHRMEN1KMT2A
SCHEMBL10871016 0.81 THRB (0.46) SMN1; SMN2ALDH1A1LMNATSHRTHRB
SCHEMBL15911020 0.81 MAPT (0.48) SMN1; SMN2ALDH1A1L3MBTL1MAPTTSHR
SCHEMBL13594741 0.80 THRB (0.45) SMN1; SMN2ALDH1A1MAPTTSHRTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2762506-B1 (METH)ACRYLOYL-TERMINATED POLYISOBUTYLENE POLYMER, METHOD FOR PRODUCING SAME, AND ACTIVE ENERGY RAY-CURABLE COMPOSITION KANEKA CORP (JP) 2022-09-07 — — EP disclosed
US-9708424-B2 (Meth)acryloyl-terminated polyisobutylene polymer, method for producing the same, and active energy ray-curable composition KANEKA CORPORATION (JP) 2017-07-18 — — US disclosed
US-20170051093-A1 (METH)ACRYLOYL-TERMINATED POLYISOBUTYLENE POLYMER, METHOD FOR PRODUCING THE SAME, AND ACTIVE ENERGY RAY-CURABLE COMPOSITION KANEKA CORP (JP) 2017-02-23 — — US disclosed
US-9512247-B2 (Meth)acryloyl-terminated polyisobutylene polymer, method for producing the same, and active energy ray-curable composition KANEKA CORPORATION (JP) 2016-12-06 — — US disclosed
US-20140243444-A1 (METH)ACRYLOYL-TERMINATED POLYISOBUTYLENE POLYMER, METHOD FOR PRODUCING THE SAME, AND ACTIVE ENERGY RAY-CURABLE COMPOSITION KANEKA CORPORATION (JP) 2014-08-28 — — US disclosed
EP-2762506-A1 (METH)ACRYLOYL-TERMINATED POLYISOBUTYLENE POLYMER, METHOD FOR PRODUCING SAME, AND ACTIVE ENERGY RAY-CURABLE COMPOSITION Kaneka Corporation (JP) 2014-08-06 — — EP disclosed
Send feedback